Epidermolysis bullosa in children: a retrospective study in a reference hospital.

Autor: Araiza-Atanacio MI; Secretaría de Salud, Instituto Nacional de Pediatría, Unidad de Apoyo a la Investigación Clínica., Gris-Calvo J; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Gastronutrición., Piña-Ramírez MJ; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Salud Mental., Cadena-León JF; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Gastronutrición., Ángeles ET; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Estomatología., Varón-Munar D; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Oftalmología., García-Romero MT; Secretaría de Salud, Instituto Nacional de Pediatría, Servicio de Dermatología. Ciudad de México, México.
Jazyk: Spanish; Castilian
Zdroj: Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2020 Sep 01; Vol. 58 (5), pp. 583-592. Date of Electronic Publication: 2020 Sep 01.
DOI: 10.24875/RMIMSS.M20000088
Abstrakt: Background: Epidermolysis bullosa (EB) is a genodermatosis caused by mutations in the proteins of the dermal-epidermal junction, altering the epithelial cohesion, and generating blisters and shedding of skin and mucous membranes.
Objective: To describe the demographic and clinical characteristics, as well as the main complications of patients with EB attended at the National Institute of Pediatrics, in Mexico City.
Method: An observational, descriptive, retrospective and cross-sectional study was conducted in patients under 18 years of age with diagnosis of EB. Patients with incomplete, purged or archived records were excluded.
Results: We included 35 patients, 17 men and 18 women with an average age of 8.94 ± 4.9 years. Patients were classified as dystrophic EB (71.4%), EB simplex (17%), junctional EB (2.9%) and Kindler syndrome (2.9%). All patients presented skin manifestations, followed by manifestations in oral mucosa (74.3%), nutritional (54.2%), gastrointestinal (51.4%), hematological (40%), ophthalmological (37.1%), musculoskeletal (34.2%) and psychosocial symptoms (34.2%). The degree of severity was variable according to the subtype; junctional EB and dystrophic EB are those that generate greater affection and comorbidity.
Conclusions: EB is a serious multisystem genetic disease, which is why it requires an early diagnosis and a timely detection of complications.
(Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social.)
Databáze: MEDLINE